Suppr超能文献

肾功能改变了稳定型缺血性心脏病治疗策略的选择和长期生存:来自艾伯塔省冠心病结局评估项目(APPROACH)注册的研究结果。

Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry.

机构信息

Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta.

Duke Clinical Research Institute, Durham, NC, USA.

出版信息

Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):274-282. doi: 10.1093/ehjqcco/qcx042.

Abstract

AIMS

Patients with chronic kidney disease (CKD) have been under-represented in stable ischaemic heart disease (SIHD) trials despite their heightened risk of cardiovascular mortality. We examine associations between kidney disease, treatment selection, and long-term survival in patients with SIHD.

METHODS AND RESULTS

SIHD patients with angiographically significant stenosis (≥70%) were categorized by renal function [dialysis-dependent, severe CKD [estimated glomerular filtration rate (eGFR) < 30], mild-moderate CKD (eGFR 30-59), and no CKD (eGFR ≥ 60)] and by treatment groups [revascularization ≤3 months of angiogram (percutaneous coronary intervention or coronary artery bypass surgery) vs. medical therapy]. The association between renal function category and treatment on long-term survival was examined and adjusted for differences in age, sex, co-morbidities, and coronary anatomy. Of the 17 910 SIHD patients, 0.7% (n = 118) were dialysis-dependent, 1.2% (n = 215) severe CKD, 12.0% (n = 2157) mild-moderate CKD, and 86.1% (n = 15420) no CKD. The presence of CKD was associated with significantly lower adjusted odds of receiving revascularization [reference no CKD: dialysis-dependent: odds ratio (OR) 0.52 (0.35, 0.79), severe (non-dialysis) CKD: OR 0.54 (0.40, 0.73), and mild-moderate CKD: OR 0.80 (0.71, 0.89)]. Over a median follow-up of 8.0 (interquartile range 3.2) years, patients with progressive CKD had higher long-term mortality (dialysis-dependent, 53.4%; severe CKD, 30.2%; mild-moderate CKD, 22.2%; no CKD, 11.9%, Ptrend < 0.0001). Revascularization was associated with improved long-term survival [adjusted hazard ratio (HR): dialysis-dependent: HR 0.29 (0.15, 0.55), severe CKD: HR 0.63 (0.36, 1.08), mild-moderate CKD: HR 0.49 (0.40, 0.60), and no CKD: HR 0.47 (0.42, 0.52)] (Pinteraction < 0.001).

CONCLUSION

In SIHD, the presence of CKD was accompanied by lower revascularization rates and a higher risk of mortality. However, revascularization in CKD was associated with improved long-term survival.

摘要

目的

尽管慢性肾脏病(CKD)患者心血管死亡率升高,但在稳定型缺血性心脏病(SIHD)试验中,他们的代表性不足。我们研究了 SIHD 患者的肾脏疾病、治疗选择与长期生存之间的关系。

方法和结果

根据肾功能[透析依赖、严重 CKD(估计肾小球滤过率[eGFR]<30)、轻度至中度 CKD(eGFR 30-59)和无 CKD(eGFR≥60)]和治疗组[血管造影后 3 个月内进行血运重建(经皮冠状动脉介入治疗或冠状动脉旁路移植术)与药物治疗],对血管造影显示有显著狭窄(≥70%)的 SIHD 患者进行分类。研究了肾功能类别与长期生存之间的关联,并对年龄、性别、合并症和冠状动脉解剖结构的差异进行了调整。在 17910 例 SIHD 患者中,0.7%(n=118)为透析依赖,1.2%(n=215)为严重 CKD,12.0%(n=2157)为轻度至中度 CKD,86.1%(n=15420)为无 CKD。存在 CKD 与接受血运重建的可能性显著降低相关[无 CKD 为参考:透析依赖:比值比(OR)0.52(0.35,0.79),非透析严重(非透析)CKD:OR 0.54(0.40,0.73),轻度至中度 CKD:OR 0.80(0.71,0.89)]。中位随访 8.0 年(四分位距 3.2 年)后,CKD 进展患者的长期死亡率较高(透析依赖:53.4%;严重 CKD:30.2%;轻度至中度 CKD:22.2%;无 CKD:11.9%,P趋势<0.0001)。血运重建与长期生存改善相关[校正后的危险比(HR):透析依赖:HR 0.29(0.15,0.55),严重 CKD:HR 0.63(0.36,1.08),轻度至中度 CKD:HR 0.49(0.40,0.60),无 CKD:HR 0.47(0.42,0.52)](P 交互<0.001)。

结论

在 SIHD 中,存在 CKD 与较低的血运重建率和更高的死亡率相关。然而,CKD 患者的血运重建与长期生存的改善相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验